BioMark is developing proprietary, non invasive, and accurate cancer diagnostic solutions which can help detect cancer early and cost effectively. The technology can also be used for measuring response to treatment and potentially for serial monitoring for cancer survivors.
Quote | BioMark Diagnostics Inc (OTCMKTS:BMKDF)
Last: | $0.2249 |
---|---|
Change Percent: | 0.0% |
Open: | $0.2249 |
Close: | $0.2249 |
High: | $0.2249 |
Low: | $0.2249 |
Volume: | 336 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | BioMark Diagnostics Inc (OTCMKTS:BMKDF)
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, is pleased to announce that the Company intends...
The Company secured collaborative research funding from Research Manitoba and Mitacs for an animal proof-of-concept study. Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced sta...
Message Board Posts | BioMark Diagnostics Inc (OTCMKTS:BMKDF)
Subject | By | Source | When |
---|---|---|---|
what do you make of this data? | MichaelVest | investorshub | 04/28/2023 4:57:47 AM |
short data if anyone is interested | MERCURIAL | investorshub | 04/27/2023 2:01:27 PM |
$BMKDF The gaining last up | MichaelVest | investorshub | 04/25/2023 8:54:07 PM |
$BMKDF Thoughts on where this is headed? | MichaelVest | investorshub | 04/21/2023 6:02:31 AM |
$BMKDF The trading | STOCKPICKER4LIFE | investorshub | 04/18/2023 2:54:18 AM |
News, Short Squeeze, Breakout and More Instantly...
BioMark Diagnostics Inc Company Name:
BMKDF Stock Symbol:
OTCMKTS Market:
BioMark Diagnostics Inc Website:
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, is pleased to announce that the Company intends...
The Company secured collaborative research funding from Research Manitoba and Mitacs for an animal proof-of-concept study. Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced sta...
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, and Rubix LS, a culturally competent patient...